Reduced critical concentration might not have improved MGIT-based DST's sensitivity to rifampicin
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Antimicrobial agents and chemotherapy - (2024) vom: 27. März, Seite e0170123 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rupasinghe, Praharshinie [VerfasserIn] |
---|
Links: |
---|
Themen: |
Borderline rpoB mutations |
---|
Anmerkungen: |
Date Revised 27.03.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1128/aac.01701-23 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370236599 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM370236599 | ||
003 | DE-627 | ||
005 | 20240328001058.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240328s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1128/aac.01701-23 |2 doi | |
028 | 5 | 2 | |a pubmed24n1351.xml |
035 | |a (DE-627)NLM370236599 | ||
035 | |a (NLM)38534101 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rupasinghe, Praharshinie |e verfasserin |4 aut | |
245 | 1 | 0 | |a Reduced critical concentration might not have improved MGIT-based DST's sensitivity to rifampicin |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 27.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
650 | 4 | |a Letter | |
650 | 4 | |a Mycobacterium tuberculosis | |
650 | 4 | |a borderline rpoB mutations | |
650 | 4 | |a rifampicin | |
700 | 1 | |a Ashraf, Azka |e verfasserin |4 aut | |
700 | 1 | |a Barreda, Nadia |e verfasserin |4 aut | |
700 | 1 | |a Parveen, Shafiqua |e verfasserin |4 aut | |
700 | 1 | |a Zubair, Muhammad |e verfasserin |4 aut | |
700 | 1 | |a Calderon, Roger |e verfasserin |4 aut | |
700 | 1 | |a Asif, Sunil |e verfasserin |4 aut | |
700 | 1 | |a Hirani, Nilma |e verfasserin |4 aut | |
700 | 1 | |a Chingisova, Layila |e verfasserin |4 aut | |
700 | 1 | |a Bulane, Atang |e verfasserin |4 aut | |
700 | 1 | |a Hang, Pham Thu |e verfasserin |4 aut | |
700 | 1 | |a Ha, Doan Thu |e verfasserin |4 aut | |
700 | 1 | |a Ardizzoni, Elisa |e verfasserin |4 aut | |
700 | 1 | |a Kursheed, Nazia |e verfasserin |4 aut | |
700 | 1 | |a De Rijk, Willem Bram |e verfasserin |4 aut | |
700 | 1 | |a Rigouts, Leen |e verfasserin |4 aut | |
700 | 1 | |a Guglielmetti, Lorenzo |e verfasserin |4 aut | |
700 | 1 | |a Mitnick, Carol |e verfasserin |4 aut | |
700 | 1 | |a de Jong, Bouke C |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Antimicrobial agents and chemotherapy |d 1972 |g (2024) vom: 27. März, Seite e0170123 |w (DE-627)NLM000026506 |x 1098-6596 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:27 |g month:03 |g pages:e0170123 |
856 | 4 | 0 | |u http://dx.doi.org/10.1128/aac.01701-23 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 27 |c 03 |h e0170123 |